Intraluminal instillation of urokinase and autologous plasma: A method to unblock occluded central venous ports

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Therapeutic use and effective function of recombinant urokinase (r-UK) for occluded ports need the presence of plasminogen. Methods: As a therapeutic proof of principle, we demonstrate that the use of r-UK and autologous plasma effectively reestablishes the function of occluded central venous ports (CVP) resistant to routine management of catheter occlusion. Five patients with occluded ports resistant to the routine management were treated. Results: All patients were success fully treated with thrombolytic therapy using intraluminal instillation of r-UK and autologous plasma. Conclusion: Instillation of r-UK and autologous plasma is a safe and effective method for management of CVP occlusion. © 2006 Seifert et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Seifert, G., Riess, H., Seeger, K., Henze, G., & Borgmann, A. (2006). Intraluminal instillation of urokinase and autologous plasma: A method to unblock occluded central venous ports. BMC Cancer, 6. https://doi.org/10.1186/1471-2407-6-103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free